Childhood cancers trials in Austria
54 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleRevumenib Treatment in Combination with FLA Chemotherapy in Paediatric Refractory/Relapsed KMT2A-r, NUP98-r or NPM1-mut Acute Myeloid Leukemia (AML)
- Where
- Vienna
- Age
- Up to 64 years
- People
- 31 worldwide
- Run by
- Pediatric Research International GmbH
See details and how to join2025-521390-14-00 · EU 2025-521390-14-00 - Phase 1Taking peopleInternational open-label phase I dose escalation study of dinutuximab beta in combination with vincristine/doxorubicin/cyclophosphamide and ifosfamide/etoposide in pediatric, adolescent, and adult patients with GD2-positive Ewing sarcoma
- Where
- Vienna
- People
- 18 worldwide
- Run by
- GPOH gGmbH
See details and how to join2024-515245-42-00 · EU 2024-515245-42-00 - No phaseTaking peopleSPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
- Where
- Vienna
- Age
- 12 years and over
- People
- 4,975 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT02834884 - Phase 2/3Taking peopleSIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependymoma
- Where
- Graz, Innsbruck, Linz, Salzburg, Vienna
- Age
- Up to 64 years
- People
- 894 worldwide
- Run by
- Centre Leon Berard
See details and how to joinNCT02265770 · EU 2024-512222-28-00 - No phaseTaking peoplePersonalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening: Advanced Brain Tumor TheRApy Clinical Trial In Patients Scheduled for shOrt Course radiatioN
- Where
- Vienna
- People
- 30
- Run by
- Medical University of Vienna
See details and how to joinNCT07627334 - Phase 3Taking peopleStudy on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
- Where
- Graz, Innsbruck, Salzburg, Vienna
- Age
- Up to 64 years
- People
- 87 worldwide
- Run by
- Universita Degli Studi Di Milano Bicocca
See details and how to join2025-520982-39-00 · EU 2025-520982-39-00 - Phase 3Taking peopleInternational Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
- Where
- Graz, Innsbruck, Linz, Salzburg, Vienna
- Age
- Up to 18 years
- People
- 683 worldwide
- Run by
- University Hospital Muenster
See details and how to joinNCT04043494 · EU 2023-508101-24-00 - Phase 3Taking peopleONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
- Where
- Vienna
- People
- 510 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT05580562 · EU 2022-502051-56-00 - No phaseNot yet taking people in AustriaPost-Market Registry of Transbronchial Cryo-assisted RFA During Routine Standard Bronchoscopic Tumor Stagng and Resection
- Where
- Linz
- People
- 20
- Run by
- Elisabethinen Hospital
See details and how to joinNCT07530744 - No phaseTaking peopleAnastomotic Bleeding in Colorectal Anastomosis Relating to the Placement of the Stapler Spike to the Staple Line
- Where
- Linz
- People
- 102
- Run by
- Kepler University Hospital
See details and how to joinNCT07506005 - No phaseTaking peopleIon Therapy Patient Registry
- Where
- Wiener Neustadt
- People
- 2,800
- Run by
- EBG MedAustron GmbH
See details and how to joinNCT03049072 - Phase 2Taking peopleInternational Study for Treatment of High Risk Childhood Relapsed ALL 2010
- Where
- Graz, Innsbruck, Linz, Salzburg, Vienna
- Age
- Up to 17 years
- People
- 250 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT03590171 · EU 2024-513070-21-00 - Phase 2/3Taking peopleA Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
- Where
- Vienna
- Age
- Up to 25 years
- People
- 210 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT05991388 · EU 2024-510575-38-00 - No phaseTaking peopleOutcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
- Where
- Vienna
- People
- 212 worldwide
- Run by
- Mayo Clinic
See details and how to joinNCT06689956 - Phase 1/2Taking peopleA Multi-Arm, Platform Trial For Relapsed Neuroblastoma
- Where
- Innsbruck, Linz, Salzburg, Vienna
- Age
- 1 year to 64 years
- People
- 160 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT07334301 · EU 2024-516115-24-00 - Phase 1/2Taking peopleBrigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors
- Where
- Vienna
- Age
- 1 year to 25 years
- People
- 65 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT04925609 · EU 2024-513412-10-00 - Phase 1Taking peopleVyClo ITCC-092
- Where
- Vienna
- Age
- Up to 64 years
- People
- 25 worldwide
- Run by
- Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2023-508050-26-00 · EU 2023-508050-26-00 - Phase 1/2Taking peopleHEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
- Where
- Vienna
- Age
- 1 year to 21 years
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05658640 · EU 2022-501869-41-00 - Phase 1/2Taking peopleHEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Where
- Vienna
- Age
- 1 year to 21 years
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05745714 · EU 2022-501867-42-01 - Phase 1/2Taking peopleHEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
- Where
- Vienna
- Age
- 1 year to 21 years
- People
- 26 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05751044 · EU 2022-501866-22-00 - Phase 1Taking peopleStudy Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
- Where
- Vienna
- Age
- 18 months to 18 years
- People
- 38 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06485947 · EU 2023-509673-22-00 - Phase 3Taking peopleHigh-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
- Where
- Graz, Innsbruck, Linz, Salzburg, Vienna
- Age
- Up to 21 years
- People
- 800 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT04221035 · EU 2024-514917-36-00 - Phase 3Taking peopleTreatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
- Where
- Graz, Innsbruck, Linz, Salzburg, Vienna
- Age
- Up to 17 years
- People
- 5,000 worldwide
- Run by
- Martin Schrappe
See details and how to joinNCT03643276 · EU 2023-509856-32-00 - No phaseTaking peopleE²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
- Where
- Graz, Linz, Vienna
- Age
- 12 years and over
- People
- 2,000 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT03818503 - No phaseEnrolling by invitationIntraoperatively Observed Site of Origin and Growth Pattern of Medulloblastoma
- Where
- Vienna
- People
- 100 worldwide
- Run by
- Christian Dorfer
See details and how to joinNCT06814353